{"title":"Have you diagnosed a patient with NMOSD or gMG?","authors":"None Alexion","doi":"10.33590/emjneurol/10300408","DOIUrl":null,"url":null,"abstract":"View our latest infographic, which provides updates in the field of neurological conditions, focusing on neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (gMG). These rare autoimmune diseases are detailed with prevalence statistics and primary treatment goals, as well as the common goal of ensuring an early and accurate diagnosis in order to optimise patient outcomes.","PeriodicalId":496518,"journal":{"name":"European Medical Journal Neurology","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Medical Journal Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjneurol/10300408","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
View our latest infographic, which provides updates in the field of neurological conditions, focusing on neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (gMG). These rare autoimmune diseases are detailed with prevalence statistics and primary treatment goals, as well as the common goal of ensuring an early and accurate diagnosis in order to optimise patient outcomes.